Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_assertion type Assertion NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_head.
- NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_assertion description "[The CD14 CC genotype was associated with incidence of new coronary occlusion (P=0.026); TNF-alpha AA genotype with history of myocardial infarction (MI, P=0.04), and A allele with total occlusions at baseline (P=0.027), and systolic blood pressure (P=0.046); and IL-6-174 CC genotype with baseline minimum lumen diameter (P=0.043) and reduction in lipoprotein(a) with fluvastatin (P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_provenance.
- NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_assertion evidence source_evidence_literature NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_provenance.
- NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_assertion SIO_000772 11199329 NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_provenance.
- NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_assertion wasDerivedFrom befree-2016 NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_provenance.
- NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_assertion wasGeneratedBy ECO_0000203 NP308209.RAzuFL3yI-sFAc9E3uzBCkCnYSmt7cZ0SMtNRI3OysMtg130_provenance.